The professional consensus in dermatology is: There is reasonable evidence for short-term brightening effects and antioxidant benefits at the cellular level Long-term safety and efficacy data are insufficient to make strong, universal clinical recommendations Medical supervision, appropriate dosing, and quality-controlled formulations are the essential safeguards that separate beneficial outcomes from adverse events WebMD's guide to glutathione provides a useful overview of potential risks and interactions for further reading
Highlight Unique Selling Points: Liposomal delivery technology for max absorption
Professor Atherton has received travel sponsorship and/or honoraria or consultancy payments (made to his employer) from or undertaken clinical trials sponsored by Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Novo Nordisk
Combined with peptide anti-inflammatory effects creates comprehensive approach
Mitochondrial fatigue, where cells are not producing energy efficiently, responds to MOTS-c, often layered with NAD+ therapy